Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis-Reference-Cited by-同舟云学术

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Published:2018-12-18 Issue:1 Volume:10 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Ge Xiaowen,Chen Jianfeng,Li Ling,Ding Peipei,Wang Qi,Zhang Wei,Li Luying,Lv Xinyue,Zhou Danlei,Jiang Zhengzeng,Zeng Haiying,Xu Yifan,Hou Yingyong,Hu Weiguo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-1259-5.pdf

Reference64 articles.

1. Bishop, P. C., Rao, V. K. & Wilson, W. H. Burkitt’s lymphoma: molecular pathogenesis and treatment. Cancer Invest. 18, 574–583 (2000).

2. Longo, D. L. et al. Diffuse small noncleaved-cell, non-Burkitt’s lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy. J. Clin. Oncol. 12, 2153–2159 (1994).

3. Jost, L. M. et al. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt’s lymphomas in adult patients. Ann. Oncol. 6, 445–451 (1995).

4. Cairo, M. S. et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 109, 2736–2743 (2007).

5. Patte, C. et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109, 2773–2780 (2007).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response;Biology;2023-07-26

2. RNA-seq analysis reveals candidate genes associated with proliferation, invasion, and migration in BCL11A knockdown B-NHL cell lines;Annals of Hematology;2023-05-06

3. Targeting Protein Kinase C for Cancer Therapy;Cancers;2022-02-22

4. Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis;Frontiers in Oncology;2021-12-08

5. Putative role of natural products as Protein Kinase C modulator in different disease conditions;DARU Journal of Pharmaceutical Sciences;2021-07-03